Application Sponsors
ANDA 206887 | MACLEODS PHARMS LTD | |
Marketing Status
Application Products
001 | TABLET;ORAL | EQ 150MG BASE | 0 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2017-10-31 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
MACLEODS PHARMS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 206887
[companyName] => MACLEODS PHARMS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"IBANDRONATE SODIUM","activeIngredients":"IBANDRONATE SODIUM","strength":"EQ 150MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/31\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2017-10-31
)
)